Wang Julia Aijun's Form 4 filing
BeOne Medicines Ltd. (ONC) · filed Jul 5, 2022
- Accession no.
- 0001651308-22-000119
- Filed
- Jul 5, 2022
- Trade date
- Jul 1, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $46.8K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001651308-22-000125 (Jul 18, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wang Julia AijunCIK 0001860279 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2022 | American Depositary Shares | SSaleDisposed | −295 | $158.50 | −$46,757.5 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.